ALPINE IMMUNE SCIENCES, INC. Lessee, Operating Lease, Liability, to be Paid, Year Two
ALPINE IMMUNE SCIENCES, INC. had Lessee, Operating Lease, Liability, to be Paid, Year Two of $2.17 million as of 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo · last filed 2024-03-20
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $2.17M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $2.11M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $2.06M.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $2.01M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Two |
|---|---|
| 2023-12-31 | $2.17M 10-K · filed 2024-03-20 |
| 2022-12-31 | $2.11M 10-K · filed 2023-03-23 |
| 2021-12-31 | $2.06M 10-K · filed 2022-03-17 |
| 2020-12-31 | $2.01M 10-K · filed 2021-03-18 |
| 2019-12-31 | $1.96M 10-K · filed 2020-03-30 |
| 2019-09-30 | $214.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $228.00K 10-Q · filed 2019-08-13 |